Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes
- 23 March 2006
- journal article
- clinical trial
- Published by Informa UK Limited in Current Medical Research and Opinion
- Vol. 22 (5), 961-966
- https://doi.org/10.1185/030079906x104632
Abstract
Objectives: The objective of this study was to describe clinical and work functional outcomes associated with 6‐month open‐label olanzapine treatment for bipolar I disorder. Methods: The study consisted of 249 patients entering a 6‐month open label phase after 12 weeks of acute double-blind haloperidol or olanzapine treatment. Baseline for analysis was defined as the beginning of open-label treatment. The clinical outcomes were symptomatic remission defined by a Y‐MRS total score ≤ 12 and a HAM‐D total score ≤ 8 at the end of 6 months of treatment. The work functional outcomes included work functional scores, the proportion of patients who reported to ‘work’ as employee, volunteers, students, or house workers and the proportion of patients who specifically reported to ‘work for pay’. Results: A total of 240 patients reported work functional outcomes post open-label baseline. Among them, 15.4% patients moved into a ‘work group’ from a ‘no-work group’ at baseline, while 7.1% did the opposite ( p = 0.0065) and 13.3% reported an improvement to ‘work for pay’ status from a ‘not working for pay’ status at baseline, while there was 4.2% of worsening in employment status ( p = 0.0007). Overall, improvement in the work functional score was found at all post-baseline time points, beginning at month two ( p = 0.003). Limitations: Results of this study need to be confirmed by double-blind randomized controlled studies. There was a lack of detailed information on work functioning from the questionnaire. Conclusions: Open‐label olanzapine treatment for 6 months was associated with improvements in work functional outcomes in patients with bipolar disorder.Keywords
This publication has 19 references indexed in Scilit:
- Medical comorbidity and health-related quality of life in bipolar disorder across the adult age spanJournal of Affective Disorders, 2005
- Burden of general medical conditions among individuals with bipolar disorderBipolar Disorders, 2004
- Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up*1Journal of Affective Disorders, 2004
- Association Between Cognitive Functioning and Employment Status of Persons With Bipolar DisorderPsychiatric Services, 2004
- A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute ManiaArchives of General Psychiatry, 2003
- Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania Results from a randomized controlled trialJournal of Affective Disorders, 2002
- Two-Year Syndromal and Functional Recovery in 219 Cases of First-Episode Major Affective Disorder With Psychotic FeaturesAmerican Journal of Psychiatry, 2000
- The epidemiology of bipolar affective disorderSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995
- The National Depressive and Manic-depressive Association (DMDA) survey of bipolar membersJournal of Affective Disorders, 1994
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978